In stock
Ircan 100 mg per 5 ml 20 mg/ml Lyophilisate for solution for injection 5ml Vial
In stock
Only 1 left
SKU
10331014212
Ircan 100 mg per 5 ml is an antineoplastic agent containing Irinotecan, indicated for the treatment of metastatic colorectal cancer. It works by inhibiting DNA topoisomerase I, disrupting cancer cell growth. Administered intravenously, this prescription-only medication requires professional medical supervision due to its potent action and potential for serious side effects.
Ircan 100 mg per 5 ml Lyophilisate for Solution for Injection contains Irinotecan, a powerful antineoplastic agent used in the treatment of various cancers.
Irinotecan is a topoisomerase I inhibitor, working by interfering with DNA replication in cancer cells, thereby preventing their growth and spread.
This medication is primarily indicated for patients with metastatic carcinoma of the colon or rectum.
It is typically used alone or in combination with other chemotherapy drugs, under strict medical supervision.
Irinotecan is a topoisomerase I inhibitor, working by interfering with DNA replication in cancer cells, thereby preventing their growth and spread.
This medication is primarily indicated for patients with metastatic carcinoma of the colon or rectum.
It is typically used alone or in combination with other chemotherapy drugs, under strict medical supervision.
Benefits of Use
- Targets and inhibits the growth of specific cancer cells.
- Effective in the treatment of metastatic colorectal cancer.
- Can be used as monotherapy or in combination regimens to improve treatment outcomes.
How to Use
- Ircan is supplied as a lyophilisate, which must be reconstituted and diluted prior to intravenous administration.
- The preparation and administration of Ircan should only be performed by trained healthcare professionals in a clinical setting.
- It is administered as an intravenous infusion, typically over 30 to 90 minutes.
- Dosage and administration schedule are highly individualized, determined by the patient's medical condition, body surface area, and response to treatment.
- Regular monitoring of blood counts and liver function is crucial during treatment.
Caution & Warnings
- Ircan can cause severe adverse reactions, including bone marrow suppression (leading to neutropenia, anemia, thrombocytopenia) and severe diarrhea.
- Close monitoring of patients for these side effects is essential, and immediate medical attention is required if they occur.
- This medication may cause fetal harm when administered to pregnant women.
- Effective contraception should be used by both male and female patients during treatment and for a period thereafter.
- Avoid concomitant use with strong CYP3A4 inhibitors or inducers, as this may alter irinotecan exposure and increase toxicity or reduce efficacy.
- Store the lyophilisate vials at controlled room temperature, protected from light.
Ingredients
Each 5 ml vial of Ircan lyophilisate contains 100 mg of Irinotecan hydrochloride trihydrate as the active ingredient, along with excipients necessary for reconstitution.
Product Details
- Form: Lyophilisate for Solution for Injection
- Strength: 100 mg per 5 ml (20 mg/ml after reconstitution)
- Package: 5 ml Vial
- Manufacturer: Adwia
- Active Ingredient: Irinotecan hydrochloride trihydrate
| Gtin | 901244688 |
|---|---|
| Recommended Sale Price | 169.05 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| Ingredient Name | IRINOTECAN |
| SFDA Reg. No | 901244688 |
| IBC | 901244688 |
| Drug Type | Prescription |
| Scientific Name | Irinotecan |
| Strength | 100 mg |
| Strength Unit | per 5 ml |
| Form | Lyophilisate for Solution for Injection |
| Admin Route | Intravenous infusion |
| Size | 5 |
| Size Unit | ml |
| Package Types | Vial |
| Package Size | 5 ml |
| Storage conditions | Store the lyophilisate vials at controlled room temperature, protected from light. |
| Refrigerator Storage | No |
Products you might like
